Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized BCMA antibody and BCMA-CAR-T cells

Humanized BCMA antibody and BCMA-CAR-T cells

US Patent 11299549 · Granted Apr 12, 2022

Estimated economic value: $9,354,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-ROR1 antibody and ROR1-targeting engineered cells2025
CS1 antibody and anti-CS1-CAR-t cells2025
Humanized BCMA antibody and BCMA-CAR-T cells2025
Epcam antibody and Epcam-CAR-T cells2025
Epcam antibody and Epcam-CAR-T cells2025
CAR-T cells with humanized CD19 ScFv with mutation in CDR 1 region2025
CAR-T cells with humanized CD19 ScFv with mutation in CDR 1 region2025
Humanized BCMA antibody and BCMA-CAR-T cells2024
Humanized BCMA antibody and BCMA-CAR-T cells2024
CAR-T cells with humanized CD19 ScFv2024
CAR-T cells with humanized CD19 ScFv2024
BCMA-CAR-T cells2024